MedPath

Tele-Electrocardiography in Emergency Cardiac Care

Phase 3
Completed
Conditions
Chest Pain
Myocardial Infarction
Registration Number
NCT00075088
Lead Sponsor
University of California, San Francisco
Brief Summary

The purpose of this study is to see whether individuals who access the "911" emergency medical system with a heart attack or severe chest pain will receive more timely hospital treatment and better outcomes if hospital clinicians are provided with earlier and more complete electrocardiography (ECG) information.

Detailed Description

This is a Phase III study. Patients will be randomized (like tossing a coin) to 1 of 2 groups: Group 1: Patients will have pre-hospital ECG intervention. Group 2: Patients will have routine emergency heart care. Information will be collected about time symptoms started, clinical management, and other measures. All patients will be contacted by telephone 12 months later and interviewed as to whether they experienced any cardiac symptoms.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
794
Inclusion Criteria
  • All individuals in Santa Cruz County in California who call 911 with symptoms of acute coronary syndrome (chest pain, shortness of breath, anginal equivalent).
Exclusion Criteria
  • Those who don't meet the above inclusion criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Hospital Time to Treatment for Patients With Unstable Angina/Non-STEMIDay 1

Time from ED arrival to first drug was determined as recommended by American College of Cardiology/American Heart Association 2007 guidelines for management of patients with unstable angina/non-STEMI

Hospital Time to Treatment for Patients With ST-elevation Myocardial Infarction (STEMI)Day 1

Mean door-to-balloon time

Secondary Outcome Measures
NameTimeMethod
Rehospitalization and Mortality4 years

Trial Locations

Locations (1)

University of California San Francisco

🇺🇸

San Francisco, California, United States

University of California San Francisco
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.